{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T07:09:16Z","timestamp":1716361756037},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.diagmicrobio.2015.03.020","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T06:18:22Z","timestamp":1428733102000},"page":"215-221","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Increased antimicrobial susceptibility rates for Pseudomonas aeruginosa bloodstream isolates across the Veterans Affairs Healthcare System"],"prefix":"10.1016","volume":"82","author":[{"given":"Chris A.","family":"Gentry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Riley J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0005","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1086\/671724","article-title":"Incidence trends in pathogen-specific central line\u2013associated bloodstream infections in US intensive care units, 1990\u20132010","volume":"34","author":"Fagan","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"15","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0010","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1007474","article-title":"Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections","volume":"364","author":"Jain","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.diagmicrobio.2009.06.022","article-title":"Antipseudomonal activity of piperacillin\/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997\u20132007)","volume":"65","author":"Jones","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0020","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/652152","article-title":"Multidrug resistance among Gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006\u20132008","volume":"31","author":"Kallen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/377200","article-title":"Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome","volume":"37","author":"Kang","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4161\/viru.22641","article-title":"Is patient isolation the single most important measure to prevent the spread of multidrug-resistant pathogens?","volume":"4","author":"Landelle","year":"2013","journal-title":"Virulence"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0035","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1128\/AAC.00338-07","article-title":"Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.03.020_bb0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijantimicag.2011.04.022","article-title":"Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009","volume":"38","author":"Master","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0045","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1128\/AAC.49.4.1306-1311.2005","article-title":"Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment","volume":"49","author":"Micek","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.diagmicrobio.2012.12.012","article-title":"Activities of carbapenem and comparator agents against contemporary US Pseudomonas aeruginosa isolates from the CAPITAL surveillance program","volume":"75","author":"Morrow","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0055","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1128\/AAC.48.12.4606-4610.2004","article-title":"National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002","volume":"48","author":"Obritsch","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0060","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/AAC.00901-06","article-title":"Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia","volume":"51","author":"Osih","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0070","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.diagmicrobio.2009.08.020","article-title":"Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999\u20132008)","volume":"65","author":"Rhomberg","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009\u20132010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2015.03.020_bb0080","series-title":"2005 Facility Complexity Model","author":"Szabo","year":"2005"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0085","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1128\/AAC.01446-09","article-title":"Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa","volume":"54","author":"Tam","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.03.020_bb0065","author":"United States Department of Veterans Affairs National Center for Veterans Analysis and Statistics"},{"key":"10.1016\/j.diagmicrobio.2015.03.020_bb0090","series-title":"Implementation of guideline for prevention of Clostridium difficile infection (CDI) in Veterans Health Administration (VHA) acute-care facilities (VAIQ # 7210267)","article-title":"Acting Assistant Deputy Under Secretary for Health for Operations and Management for Clinical Operations (10NC)","author":"VHA Memorandum","year":"2012"},{"key":"10.1016\/j.diagmicrobio.2015.03.020_bb0095","author":"Veterans Healthcare Administration"},{"key":"10.1016\/j.diagmicrobio.2015.03.020_bb0100","author":"Veterans Healthcare Administration"},{"issue":"18","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0105","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1001\/archinte.1996.00440170139015","article-title":"Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes","volume":"156","author":"Vidal","year":"1996","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2015.03.020_bb0115","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2015.03.020_bb0110","author":"World Health Organization (WHO)"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889315001121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889315001121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T11:58:31Z","timestamp":1537703911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889315001121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0732889315001121"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.03.020","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased antimicrobial susceptibility rates for Pseudomonas aeruginosa bloodstream isolates across the Veterans Affairs Healthcare System","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}